Millipore Sigma Vibrant Logo

09-481 Anti-PI3 Kinase Antibody, p110α

Detect PI3 Kinase using this Anti-PI3 Kinase Antibody, p110α validated for use in WB, IP, IH, ELISA.

Anti-PI3 Kinase Antibody, p110α MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
Research Category: Signaling Research Sub-Category: PI3K, Akt, & mTOR Signaling Gene Symbol: EC 2.7.1.153 , MGC142161, MGC142163, PI3K, p110-alpha UniProt Number: P42336
View Products on Sigmaaldrich.com
09-481
100 µg  
正在检索价格......
无法检索价格。
最小订购数量为倍数
Maximum Quantity is
以订单确认为准 更多信息
您节约了 ()。
 
—
Request Pricing
—
目前缺货 目前缺货
有货 
停产
少量现货
供货情况有待确认
    其余：另行通知
      其余：另行通知
      另行通知
      联系客户服务
      Contact Customer Service

      特卖

       

      联系客户服务

      概述

      Replacement Information

      特卖

      100% Performance Guaranteed

      重要规格表

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      H, RWB, IP, IHC, ELISARbAffinity PurifiedPolyclonal Antibody
      Description
      Catalogue Number09-481
      Replaces04-399
      DescriptionAnti-PI3 Kinase Antibody, p110α
      Alternate Names
      • PI3-kinase p110 subunit alpha
      • PtdIns-3-kinase p110
      • phosphatidylinositol 3-kinase, catalytic, 110-KD, alpha
      • phosphatidylinositol 3-kinase, catalytic, alpha polypeptide
      • phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit, alpha isoform
      • phosphoinositide-3-kinase, catalytic, alpha polypeptide
      Background InformationPhosphoinositol-3-kinases (PI3 Kinase, PI3K) are a family of lipid kinases that mediate many intracellular signaling responses in both physiological and pathophysiological states. PI3 Kinase is a heteroduplex with three classes (I, II, & III) of catalytic domain. The class I PI3 Kinases are made up of a p85 regulatory protein and a p110 catalytic domain. There are 4 isoforms of the class I p110 catalytic domains. Class I(A) include α, β, γ and class I(B). They are activated downstream via receptor tyrosine kinases or G-protein coupled receptors. Once activated, PI3K generates phosphatidylinositol 3,4,5-trisphosphate (PIP3) from PIP2. It was later found that PTEN, a lipid phosphatase, acts opposite to PI3K by dephosphorylating PIP3, converting it to PIP2, thus de-activating the effects of PI3K. Increased levels of PIP3 in the cell leads to the activation of many key signaling regulators including Akt and PDK as well as calcium release. One of the primary roles of PI3K is its regulation of cell growth and cell metabolism. Both of these play a critical role in cancer as some believe that a tumor’s shift to glycolysis is due to the activation of PI3K. PI3 kinases have been linked with numerous disease states, including cancer, diabetes, allergic response, hypertension, cardiac contractility, atherosclerosis, sepsis and autoimmune/ inflammatory disorders.
      References
      Product Information
      FormatAffinity Purified
      PresentationPurified rabbit polyclonal in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl, and 0.05% sodium azide.
      Quality LevelMQ100
      Applications
      ApplicationDetect PI3 Kinase using this Anti-PI3 Kinase Antibody, p110α validated for use in WB, IP, IH, ELISA.
      Key Applications
      • Western Blotting
      • Immunoprecipitation
      • Immunohistochemistry
      • ELISA
      Biological Information
      ImmunogenKLH-conjugated synthetic linear peptide corresponding to an internal region of class I catalytic domain of PI3 Kinase that is specific to the p110 alpha isoform.
      EpitopeInternal
      ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
      HostRabbit
      SpecificityRecognizes PI3 Kinase p110α.
      Species Reactivity
      • Human
      • Rat
      Species Reactivity NotePurified rabbit polyclonal in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl, and 0.05% sodium azide.
      Antibody TypePolyclonal Antibody
      Entrez Gene Number
      Entrez Gene SummaryPhosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. This gene has been found to be oncogenic and has been implicated in cervical cancers. [provided by RefSeq].
      Gene Symbol
      • EC 2.7.1.153
      • MGC142161
      • MGC142163
      • PI3K
      • p110-alpha
      Purification MethodImmunogen Affinity Purified
      UniProt Number
      UniProt SummaryFUNCTION: Phosphorylates PtdIns, PtdIns4P and PtdIns(4,5)P2 with a preference for PtdIns(4,5)P2.

      CATALYTIC ACTIVITY: ATP + 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate = ADP + 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate.

      SUBUNIT STRUCTURE: Heterodimer of a p110 (catalytic) and a p85 (regulatory) subunit. Binds to IRS1 in nuclear extracts. Interacts with RUFY3 By similarity.

      INVOLVEMENT IN DISEASE: Defects in PIK3CA are associated with colorectal cancer (CRC) [MIM:114500].
      Defects in PIK3CA are associated with breast cancer [MIM:114480].
      Defects in PIK3CA are associated with ovarian cancer [MIM:167000]. Ovarian cancer is the leading cause of death from gynecologic malignancy. It is characterized by advanced presentation with loco-regional dissemination in the peritoneal cavity and the rare incidence of visceral metastases. These typical features relate to the biology of the disease, which is a principal determinant of outcome.
      Defects in PIK3CA may underlie hepatocellular carcinoma (HCC) [MIM:114550]. Ref.14
      PI3KCA mutations affecting exons 9 and 20 display gender- and tissue-specific patterns, thus suggesting that the different amino acid changes could exert distinct functional effects on the oncogenic properties of this enzyme. Furthermore, sexual dimorphisms and tissue specific factors might directly or indirectly influence the occurrence of PI3KCA cancer alleles.

      SEQUENCE SIMILARITIES: Belongs to the PI3/PI4-kinase family.
      Contains 1 C2 domain.
      Contains 1 PI3K/PI4K domain.
      Molecular Weight110 kDa
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by western blot on Jurkat cell extract.

      Western Blotting Analysis: 0.5 µg/mL (1:2,000) dilution of this antibody detected PI3K, p110α in Jurkat cell extract.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at 2-8ºC from date of receipt.
      Packaging Information
      Material Size100 µg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      产品目录编号 GTIN
      09-481 04053252363818

      Documentation

      Anti-PI3 Kinase Antibody, p110α MSDS

      职位

      物料安全数据表 (MSDS) 

      Anti-PI3 Kinase Antibody, p110α 分析证书

      标题批号
      Anti-PI3 Kinase, p110a - 2179367 2179367
      Anti-PI3 Kinase, p110a - NG1618266 NG1618266
      Anti-PI3 Kinase, p110a - NG1661341 NG1661341
      Anti-PI3 Kinase, p110a - NG1734871 NG1734871
      Anti-PI3 Kinase, p110a - NG17490006 NG17490006
      Anti-PI3 Kinase, p110a - NG1809731 NG1809731
      Anti-PI3 Kinase, p110α - 2411905 2411905
      Anti-PI3 Kinase, p110α - 2441452 2441452
      Anti-PI3 Kinase, p110α - 3212770 3212770
      Anti-PI3 Kinase, p110α - 3698142 3698142
      Show more

      小册子

      标题
      Advancing cancer research: From hallmarks & biomarkers to tumor microenvironment progression